Amorfix announces vCJD blood test breakthrough
Canada's Amorfix Life Sciences reports 100% sensitivity and 100% specificity for its EP-vCJD test in a second blinded trial of human blood samples, in collaboration with the UK's National Institute for Biological Standards and Control (NIBSC).
Tuesday 6 January 2009

Axis-Shield, Abbott to develop Active-B12 test
Axis-Shield and Abbott Laboratories agree to develop and manufacture an active-B12 assay to run on Abbott’s line of Architect automated immunoassay analysers.
Thursday 18 December 2008

US FDA updates guidance on PMA supplements
The US FDA publishes a guidance document on December 11 that advises industry on the regulatory pathway to take when companies modify class III devices that are subject to premarket approval (PMA).
Wednesday 17 December 2008

New pacemaker connector must be tested before, not after, FDA approval, scientists say
The US FDA is allowing the sale of potentially dangerous pacemaker equipment, two high-profile cardiologists allege.
Wednesday 17 December 2008

Early data back Thoratec's HeartMate II as destination therapy
The HeartMate II left ventricular assist device (LVAS) developed by Thoratec is much more effective than a previous model, early trial results have shown.
Tuesday 9 December 2008

Clinica at RSNA 2008: An interactive feature
This year's Radiological Society of North America (RSNA) conference, held in Chicago, Illinois, had a different focus to last year's, which was dominated by CT's "slice war", says Madeleine Armstrong. Companies are now insisting that the slice war is over, and are focusing on other CT technologies such as spectral imaging.
Tuesday 9 December 2008

Philips swings the axe at healthcare unit as credit crunch bites into imaging sales
Philips' healthcare division to axe 1,600 jobs; rival GE posts weak Q3 results last month, fuelling speculation over job cuts.
Thursday 27 November 2008

J&J set to boost surgery business with $438m in Omrix buy
In a bid to strengthen its biosurgical products business, Johnson & Johnson agrees to purchase Omrix Biopharmaceuticals for $438m in an all-cash deal.
Thursday 27 November 2008

Siemens to unveil "fastest" and "lowest dose" CT at RSNA
Siemens Healthcare will introduce its new CT scanner, the Somatom Definition Flash, at the Radiological Society of North America (RSNA) meeting next week. The firm claims that the device combines "unprecedented speed…with the lowest dose you can see today in any CT scanner".
Wednesday 26 November 2008

Medica 2008: Olympus unveils AU480 clinical chemistry analyser
Olympus’s new analyser comes with "user-friendly" safety features to "maximise output and minimise downtime".
Thursday 20 November 2008

Previous 1 2 3 4 Next